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Abstract
Ribosome biogenesis is a ubiquitous and essential process in cells. Defects in ribosome bio-
genesis and function result in a group of human disorders, collectively known as ribosomopa-
thies. In this study, we describe a zebrafish mutant with a loss-of-function mutation in nol9, a
gene that encodes a non-ribosomal protein involved in rRNA processing. nol9sa1022/sa1022
mutants have a defect in 28S rRNA processing. The nol9sa1022/sa1022 larvae display hypoplastic
pancreas, liver and intestine and have decreased numbers of hematopoietic stem and progeni-
tor cells (HSPCs), as well as definitive erythrocytes and lymphocytes. In addition, ultrastructural
analysis revealed signs of pathological processes occurring in endothelial cells of the caudal
vein, emphasizing the complexity of the phenotype observed in nol9sa1022/sa1022 larvae. We fur-
ther show that both the pancreatic and hematopoietic deficiencies in nol9sa1022/sa1022 embryos
were due to impaired cell proliferation of respective progenitor cells. Interestingly, genetic loss
of Tp53 rescued the HSPCs but not the pancreatic defects. In contrast, activation of mRNA
translation via the mTOR pathway by L-Leucine treatment did not revert the erythroid or pan-
creatic defects. Together, we present the nol9sa1022/sa1022mutant, a novel zebrafish ribosomo-
pathy model, which recapitulates key human disease characteristics. The use of this
genetically tractable model will enhance our understanding of the tissue-specific mechanisms
following impaired ribosome biogenesis in the context of an intact vertebrate.
Author Summary
The production of ribosomes, the protein-synthesizing machines, is fundamental in all
cells. It is a very complex process that requires the coordinated actions of ribosomal and
non-ribosomal proteins. Impairment of ribosome formation and function leads to a class
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of disorders known as “ribosomopathies”. Here, we describe the identification and charac-
terization of a zebrafish mutant in nol9, a gene encoding a non-ribosomal protein involved
in ribosome biogenesis. The nol9sa1022/sa1022 mutants show defects in the exocrine pancreas
and erythrocytes due to impaired cell proliferation. These phenotypic features of
nol9sa1022/sa1022 mutants are reminiscent of the clinical symptoms of Shwachman-Dia-
mond syndrome, a ribosomopathy characterized by exocrine pancreatic insufficiency and
hematopoietic defects. Interestingly, we found that hematopoiesis but not pancreas mor-
phogenesis in nol9sa1022/sa1022 larvae is Tp53-dependent, highlighting that the conse-
quences of impaired ribosome biogenesis differ between tissues within the same organism.
This study provides novel insight into the function of the ribosome biogenesis protein
Nol9 in zebrafish development and presents a novel model that will help to decipher the
tissue-specific mechanisms of ribosomopathies.
Introduction
Ribosome biogenesis is a highly conserved and remarkably complex process that is essential for
cell growth and proliferation. It utilizes 60% of total cellular transcription in a growing yeast
cell, with 2,000 ribosomes synthesized every minute [1]. It requires the coordinated action of
all three RNA polymerases (RNAP I, II, III) and the synthesis of 4 ribosomal RNAs (rRNAs),
82 core ribosomal proteins (RPs), more than 200 non-ribosomal proteins and approximately
70 small nucleolar RNAs (snoRNAs) [2]. While complete loss of expression of genes encoding
ribosomal components has not been described in humans, haploinsufficiency or partial loss of
protein expression of some ribosome biogenesis proteins has been shown to be a common
basis of the group of disorders known collectively as “ribosomopathies” [3]. Although all ribo-
somopathies involve ribosomal dysfunction, they show different modes of inheritance and the
clinical presentations may vary even among patients carrying the same mutation. Clinical fea-
tures of the ribosomopathies include defects in growth and development, craniofacial and skel-
etal defects, hematological abnormalities with increased propensity to the development of
malignancies such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
[3]. Ribosomopathies that present with hematological defects include Diamond Blackfan ane-
mia (DBA), 5q- syndrome, Shwachman-Diamond syndrome (SDS) and T-cell acute lympho-
blastic leukemia (T-ALL). Additional examples of ribosomopathies include Treacher Collins
syndrome (TCS), isolated congenital asplenia (ICAS), aplasia cutis congenita (ACC), Bowen-
Conradi syndrome (BCS), North American Indian Childhood cirrhosis (NAIC) and alopecia,
neurological defects and endocrinopathy (ANE) syndrome [4].
One of the most intriguing aspects of ribosomopathies is that, despite the fact that they all
share a common defect in the same biological process there is a high degree of cell and tissue-spe-
cific pathology [5]. Evidence from a number of model systems suggested activation of Tp53 [6–
16] and mTOR [17, 18] pathways following ribosome dysfunction. However, modulation of
these pathways had variable success in reverting tissue specific phenotypes in different models of
ribosomopathies, again emphasizing the complexity of these disorders. This lack of basic insight
into the molecular and biochemical defects that underlie ribosomopathies is reflected by a lack of
effective therapeutic strategies, often resulting in poor outcomes for patients suffering from these
disorders [3]. Current therapies include steroids and chronic transfusions for DBA patients and
pancreatic enzyme replacement, granulocyte colony-stimulating factor, antibiotics and transfu-
sion support for SDS patients. The only definitive treatment for the hematopoietic defects in
DBA and SDS is bone marrow transplantation [19, 20]. However, graft failure, graft versus host
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disease and infection contribute to the substantial morbidity and mortality associated with these
treatments [19, 21]. Therefore, there is a need to develop novel, targeted, therapeutic strategies
based on understanding the pathophysiology of these disorders; which is why ongoing work to
generate optimal in vivomodels is essential for further progress in the field.
Here we report the identification and analysis of a zebrafish mutant with a loss-of-function
mutation in the nol9 gene. The human NOL9 protein is a polynucleotide 5’-kinase involved in
ribosome biogenesis [22]. It is a non-ribosomal protein that is required for cleavage of the ITS2
region from a pre-rRNA to generate 5.8S and 28S rRNAs and for the synthesis of the 60S ribo-
somal subunit [22]. Similarly, the NOL9 homolog in S. pombe, Grc3, is required for pre-rRNA pro-
cessing, particularly ITS2 processing [23]. In this study, we demonstrate that nol9sa1022/sa1022
mutants have a defect in pre-rRNA processing within ITS2. As in the majority of congenital syn-
dromes in human, zebrafish nol9sa1022/sa1022 larvae had multiple organ failures including intestine,
liver, pancreas and impaired definitive erythropoiesis and lymphopoiesis. These phenotypic fea-
tures of nol9sa1022/sa1022mutants are reminiscent of the clinical symptoms of Shwachman-Dia-
mond syndrome, an autosomal recessive ribosomopathy [24–27] that is characterized by exocrine
pancreatic insufficiency, hematological abnormalities including neutropenia, anemia and throm-
bocytopenia and skeletal defects. Our detailed characterization of nol9sa1022/sa1022 larvae further
shows that both pancreatic and erythroid defects are due to impaired proliferation as well as differ-
entiation of respective progenitor cell types. Additionally, we show that impaired erythropoiesis,
but not pancreatic development, is rescued in double knock out nol9sa1022/ sa1022/tp53zdf1/zdf1 larvae.
Results
nol9sa1022/sa1022 zebrafish mutants display impaired development of the
intestine, liver, pancreas and definitive erythrocytes
The nol9sa1022/sa1022mutant was first identified in the Zebrafish Mutation Project, and it carries a
nonsense mutation in codon 195 of the gene (Fig 1A) [28, 29]. nol9sa1022/sa1022 embryos developed
normally during the first 72 hpf with no obvious morphological differences when compared to het-
erozygous (nol9+/sa1022) or wild-type (wt) siblings. However, at 96- and 120 hpf, the nol9sa1022/sa1022
larvae lacked intestinal folds, had a smaller liver and pancreas and exhibited impaired yolk absorp-
tion compared to wt siblings (Figs 1B and 1C and S1A–S1C). Additionally, over 90% of the
nol9sa1022/sa1022 fish failed to inflate their swim bladder. The digestive organ phenotype was
completely penetrant and the nol9sa1022/sa1022 larvae died by 10 days post fertilization (dpf).
Some common features of ribosomopathies include craniofacial and hematological defects
[30]. At 120 hpf, the nol9sa1022/sa1022 larvae displayed normal jaw and branchial arch structures
indicating that nol9 is not required for normal skeletal development (S1D Fig). We also exam-
ined erythropoiesis in our model. Zebrafish erythropoiesis, similar to mammals, occurs in two
sequential waves: primitive and definitive. While primitive erythropoiesis was intact at all the
time points examined (48-, 96- and 120 hpf) as assessed by o-Dianisidine staining (S2A–S2D
Fig), nol9sa1022/sa1022 larvae displayed a dramatic decrease in the number of hbae1-positive
definitive erythrocytes in the caudal hematopoietic tissue (CHT) at 96- (S2E and S2F Fig) and
120 hpf (Fig 1D and 1E). These results strongly suggest that nol9 is critical for the production
of definitive but not primitive erythrocytes.
nol9 expression is consistent with digestive organ and hematological
defects of nol9sa1022/sa1022mutants
Although ribosomopathies are characterized by mutations in components of a fundamental
process in all cells, the clinical manifestations vary and display tissue specificity. One of the
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hypotheses that has been proposed to explain this tissue specificity is the distinct expression
pattern of genes involved in ribosomal biogenesis [31]. We therefore assessed the expression of
nol9 during early zebrafish development using whole-mount in situ hybridization (WISH)
(Fig 2A). nol9 is ubiquitously expressed at 4- and 12 hpf but its expression is not apparent at
48- hpf (Fig 2A). At 72 hpf, the expression of nol9 is evident only in the branchial arches. At
96 hpf, nol9 expression is restricted to the branchial arches and pancreas. Finally, at 120 hpf,
strong expression of nol9 is present in the branchial arches, liver, pancreas, as well as the
CHT, which is consistent with the observed digestive organ and hematological defects of
nol9sa1022/sa1022 larvae.
Fig 1. Loss-of-function nol9mutation leads to defects in the development of the intestine, liver, pancreas and definitive erythrocytes in zebrafish.
(A) Schematic representation of the nol9 gene and protein. Vertical bars represent exons (black boxes) and UTRs (grey boxes). The nonsense point
mutation in nol9sa1022 is marked in red. Wild-type Nol9 protein and its expected truncated version resulting from the nol9sa1022 allele are shown. Domains of
the Nol9 protein are indicated by grey boxes. P—P-loop NTP-ase domain. (B) Representative DIC images of nol9+/+ and nol9sa1022/sa1022 larvae at 120 hpf.
Left and right sides of each larva are shown. White arrow points to the liver. Black arrow shows the swim bladder. Pancreas is outlined in yellow. (C)
Representative bright filed images of the intestinal folds at 120 hpf. The nol9sa1022/sa1022mutant larvae have less developed intestinal folds (black arrowhead)
compared to nol9+/+ siblings. (D) Whole-mount in situ hybridization using hbae1 riboprobe at 120 hpf. Arrow indicates hbae1-positive definitive erythrocytes
present in the CHT of nol9+/sa1022 and nol9+/+ but not nol9sa1022/sa1022 embryos. (E) Quantification of hbae1 in situ hybridization data. Data are represented as
the number of larvae belonging to each phenotypic group. Fisher’s exact test, **, p<0.01.
doi:10.1371/journal.pgen.1005677.g001
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Zebrafish Nol9 is required for 28S rRNA processing
Mature 5.8S, 18S and 28S rRNAs are produced from the 45S pre-rRNA transcript by a series of
enzymatic cleavage steps (Fig 2B). Human NOL9 protein (like its homolog Grc3 in S. pombe
[23]) is a polynucleotide 5’-kinase that is required for the efficient processing of the 32S precur-
sor into 5.8S and 28S rRNAs in HeLa cells [22]. To investigate the role of Nol9 in zebrafish, we
performed Northern blot analysis (Fig 2B–2D) using probes designed to hybridize to the exter-
nal (5’ETS) and internal transcribed spacer (ITS1 and ITS2) regions of zebrafish 45S pre-
rRNA. These probes detect the full-length rRNA precursor and all intermediate species, but
not the mature rRNAs. We detected accumulation of the full-length precursor ‘a’ and of the
intermediates ‘b’ and ‘c’ in nol9sa1022/sa1022 mutants compared to wt siblings at 120 hpf (Fig 2B
and 2C). Based on the relative signal intensities of the intermediate bands, we conclude that the
block in rRNA processing in nol9sa1022/sa1022 mutants occurs at the level of the intermediate ‘c’,
which corresponds to the 27SB precursor in yeast and 32S in human [22, 23]. Therefore, the
function of Nol9 in ITS2 processing is conserved across yeast, zebrafish and human cells [22,
23]. We hypothesize that the presence of intermediate ‘b’ reflects an alternate cleavage pathway
Fig 2. Loss-of-function nol9mutation leads to a defect in ITS2 pre-rRNA processing. (A) Expression pattern of nol9 byWISH at sphere stage (4 hpf), 12
hpf, 48 hpf, 72 hpf, 96 hpf and 120 hpf. Black arrows indicate branchial arches, white arrow indicates pancreas and arrowhead indicates nol9-expressing
cells in the CHT. (B) Representative Northern blot analysis of RNA isolated from 5 dpf nol9sa102/sa10222mutants and control (nol9+/+ and nol9+/sa1022) siblings
using 5’ETS, ITS1 and ITS2 probes to detect rRNA processing intermediates. Corresponding rRNA intermediates (a, b, c, d) are indicated in B) and C). (C)
Schematic representation of the rRNA intermediates detected in the Northern blot analysis. The sites of hybridization of the 5’ETS, ITS1 and ITS2 probes are
indicated in red. (D) Methylene blue staining of the membrane was used to control for equal loading of RNA. wt–nol9+/+/nol9+/sa1022, mut–nol9sa1022/sa1022.
doi:10.1371/journal.pgen.1005677.g002
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[32]. Methylene blue staining of ribosomal RNAs after Northern transfer was used to confirm
equal loading of samples (Fig 2D). Furthermore, E-bioanalyzer analysis revealed a decrease in
mature 28S rRNA in nol9sa1022/sa1022 larvae compared with nol9+/+nol9+/sa1022 siblings at 120
hpf, while mature 18S rRNA was unaffected (S3A and S3B Fig).
nol9 is essential for development of zebrafish pancreatic acinar and duct
cells
During pancreas development, contiguous areas of the gut bud sequentially. The first postero-
dorsal bud develops into the endocrine principal islet whereas the second anteroventral bud
gives rise to exocrine tissue, pancreatic ducts and late-forming endocrine cells [33, 34]. To
dissect the role of nol9 in pancreatic cell lineage development, we generated nol9sa1022/sa1022
zebrafish in a Tg(ins:mCherry)jh2/Tg(ptf1a:EGFP)jh1 background [35, 36]. This allowed
us to visualize ins:mCherryjh2-expressing endocrine β-cells in conjunction with ptf1a:
EGFPjh1-expressing exocrine pancreatic cells in nol9sa1022/sa1022 embryos and their wt siblings.
In both wt and nol9sa1022/sa1022 larvae, β-cells localized appropriately and maintained the
normal islet volume from 48- to 120 hpf (Figs 3A and S4A). Furthermore, the volume of
somatostatin-producing δ-cells and glucagon-producing α-cells was comparable between
nol9sa1022/sa1022 mutants and wt siblings at 96 hpf (S4B Fig). Thus, our data strongly suggest
that the development of the endocrine pancreatic islet in nol9sa1022/sa1022 larvae is normal.
In contrast, the ptf1a-positive exocrine pancreas appeared smaller in nol9sa1022/sa1022 larvae
compared to wt siblings after 72 hpf (Figs 3A and S4A and S4C). This phenotype was recapitu-
lated by microinjection of one-cell stage zebrafish embryos with the translation blocking mor-
pholino oligonucleotide targeted to nol9mRNA (S5 Fig). Transmission electron microscopy
(TEM) analysis revealed that exocrine pancreatic cells in nol9sa1022/sa1022 larvae lacked rough
endoplasmic reticulum (RER) and had fewer and smaller zymogen granules compared to wt
siblings (Fig 3B). This was in line with the observed decrease in overall protein synthesis in
nol9sa1022/sa1022 mutants compared to wt siblings at 120 hpf, as assessed by puromycin incorpo-
ration assay (S6 Fig). In addition, the mitochondria in exocrine pancreatic cells appeared
enlarged and abnormal in nol9sa1022/sa1022 mutants compared to wt siblings (Fig 3B). However,
carboxypeptidase-a (α-Cpa), an exocrine pancreatic enzyme [37], was detected by immunohis-
tochemistry in both nol9sa1022/sa1022 mutants and wt siblings at 120 hpf (Fig 3C). This suggests
that even though the morphology of acinar cells is severely affected in nol9sa1022/sa1022 mutants,
the differentiation of exocrine pancreatic cells into acinar cells is normal.
The pancreatic ducts and secondary islets are also derived from the anteroventral bud,
therefore we wished to examine if their formation was affected by the loss-of-function muta-
tion in nol9. Immunohistochemistry against α-cytokeratin, a marker of pancreatic ductular
epithelia [38], revealed that nol9sa1022/sa1022 larvae failed to form pancreatic ducts (Fig 3D) thus
mirroring the defective morphogenesis of ptf1a-positive progenitors. Finally, we investigated
secondary islet formation in nol9sa1022/sa1022 larvae. The secondary islets arise from Notch-
responsive progenitor cells that reside in the main pancreatic duct [39, 40]. Since the number
of ins:mCherryjh2-expressing β-cells of the secondary islets is scarce in wt larvae at 120 hpf, we
utilized Notch inhibition as a way to accelerate differentiation of the endocrine cells of the sec-
ondary islets [39]. We incubated nol9sa1022/sa1022 embryos and their wt siblings in either
100 μM of Notch inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl
ester (DAPT) or dimethyl sulfoxide (DMSO), as a control, from 72 to 120 hpf. The DAPT
treatment resulted in a comparable increase in the percentage of both nol9sa1022/sa1022 larvae
and wt siblings displaying ins:mCherryjh2-expressing secondary islets compared to DMSO
treated embryos (S7A and S7B Fig). Our observations suggest that the relative number of
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secondary islet progenitor cells is retained even in the absence of Nol9. Overall we conclude
that the defects arising from the loss-of-function nol9mutation affect only cells of the exocrine
pancreas, namely the acinar and pancreatic duct cells.
nol9sa1022/sa1022 embryos have impaired proliferation of exocrine
pancreatic cells
The reduced size of the exocrine pancreas in nol9sa1022/sa1022 larvae at 96 hpf could be attributed
to increased apoptosis and/or impaired cell proliferation. The terminal deoxynucleotidyl trans-
ferase dUTP nick end labelling (TUNEL) assay revealed apoptotic cells in different areas of the
zebrafish, including the tail, but none in the pancreas of either nol9sa1022/sa1022 or their wt siblings
at 96 hpf (S7C and S7D Fig). These data indicate that apoptosis does not contribute to the exo-
crine pancreatic defect in nol9sa1022/sa1022 mutants. In order to examine cell proliferation in the
pancreas of nol9sa1022/sa1022 larvae, we measured 5-bromo-2’-deoxyuridine (BrdU) incorporation
Fig 3. nol9mutation affects the development of the exocrine but not the endocrine pancreas. (A) Representative single channel confocal images of the
pancreas of 96 hpf Tg(ptf1a:EGFP;ins:mCherry) larvae. nol9sa1022/sa1022 larvae were characterized by smaller ptf1a-positive area (green) and similar ins-
positive area (red) compared to nol9+/+ siblings. (B) TEM pictures of the exocrine pancreas of nol9+/+ and nol9sa1022/sa1022 larvae at 120 hpf. The white arrow
denotes endoplasmic reticulum in the nol9+/+ cell. Asterisks indicate zymogen granules. Arrowheads indicate mitochondria. Scale bar: 2 μm. (C-D) Confocal
images of the pancreas of Tg(ptf1a:EGFP) larvae subjected to immunohistochemistry against α-Carboxypeptidase-a (α-Cpa) (C) and α-Cytokeratin (D) at
120 hpf. (C) The exocrine pancreas differentiation marker α-Cpa (red) was detected in nol9+/+ and nol9sa1022/sa1022 siblings. (D) The pancreatic ducts
expressing α-Cytokeratin (red) are not apparent in nol9sa1022/sa1022mutants, in contrast to the ductal network clearly visible in nol9+/+ siblings.
doi:10.1371/journal.pgen.1005677.g003
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in 96 hpf larvae from a Tg(ptf1a:EGFP)/nol9+/sa1022 x Tg(ptf1a:EGFP)/nol9+/sa1022 cross. We
detected fewer ptf1a-expressing cells in S phase after normalising for pancreatic volume in
nol9sa1022/sa1022mutants compared to siblings control (S8A and S8B Fig). Thus, the impaired
expansion of the pancreas in nol9sa1022/sa1022mutants most likely results from decreased cell pro-
liferation of pancreatic progenitor cells.
Loss of nol9 function reduces the proliferation of HSPCs and disrupts
the cellular architecture of the CHT
Hematological defects in ribosomopathies often include, but are not limited to, anemia. In
Shwachman-Diamond Syndrome, the most common hematological symptom is
neutropenia, followed by anemia and thrombocytopenia [41]. To dissect hematological defects
caused by the loss-of-function mutation in nol9, we evaluated blood lineage differentiation in
nol9sa1022/sa1022 larvae and their heterozygous and wt siblings. Interestingly, while nol9 was
essential for definitive erythropoiesis (Fig 1C), all larvae from a Tg(cd41:EGFP)/nol9+/sa1022 x
nol9+/sa1022 cross had comparable numbers of cd41high thrombocytes at 96 hpf (S9A and S9B
Fig). Since thrombocytes are the ontogenetically closest lineage to definitive erythrocytes, these
data suggest that the thrombocyte-erythroid progenitors are not affected in nol9sa1022/sa1022
fish. Similarly, we did not observe a significant difference in the number of neutrophils between
nol9sa1022/sa1022 larvae and their wt siblings at 72 hpf, as assessed by Sudan Black staining (S9C
and S9D Fig). In contrast, in situ hybridization using rag1 riboprobe revealed that the number
of lymphocytes in nol9sa1022/sa1022 larvae was markedly decreased compared to heterozygous
and wt siblings at 96 hpf (Fig 4A and 4B). However, nol9sa1022/sa1022 mutants and wt siblings
showed comparable levels of expression of the thymic epithelial marker foxn1 [42], as assessed
by in situ hybridization at 96 hpf (Fig 4C). These data suggest that in nol9sa1022/sa1022 mutants
the development of the thymus is unaffected compared to wt siblings and that the observed
decrease in the number of lymphocytes is not secondary to a defect of the thymic niche.
To further investigate the mechanism behind defects in hematopoiesis in nol9sa1022/sa1022
embryos, we assessed the temporal expression of one of the early markers of hematopoietic
stem cells (HSCs), the transcriptional activator c-myb [43]. In situ hybridization using c-myb
riboprobe revealed that the specification of HSCs in the aorta–gonad–mesonephros (AGM)
was normal in nol9sa1022/sa1022 embryos at 36 hpf (Fig 4D). However, the number of hemato-
poietic stem and progenitor cells (HSPCs) was markedly decreased in the CHT at 72 hpf (Fig
4D). These data were further corroborated by flow cytometric analysis of c-myb+ cells in wt
and nol9sa1022/sa1022 larvae at 96 hpf. We detected a significant decrease in the number of
EGFP+ cells sorted from the dissected CHT region of Tg(c-myb:EGFP)/nol9sa1022/sa1022 com-
pared to Tg(c-myb:EGFP)/nol9+/+ larvae (S10A–S10C Fig). Quantification of HSPCs using the
Tg(cd41:EGFP) line [44] confirmed a decrease in the number of cd41low (GFPdim) HSPCs in the
CHT of nol9sa1022/sa1022 mutants compared to wt siblings at 96 hpf (Fig 5A and 5B). Similar to
our earlier observations in the pancreas, the reduced number of c-myb+ cells was not due to
increased apoptosis in the CHT region of nol9sa1022/sa1022 larvae (S11 Fig). Instead, 5-bromo-2'-
deoxyuridine (BrdU) incorporation assay revealed that the proliferation of HSPCs was signifi-
cantly decreased in nol9sa1022/sa1022 embryos at 48 hpf (Fig 5C–5E). This led us to conclude that
the decrease in the number of HSPCs in nol9sa1022/sa1022 larvae at 72 hpf is due to a defect in
HSPC proliferation and not due to increased apoptosis.
Although the gross morphology of the CHT and vessels appeared normal in nol9sa1022/sa1022
mutants, we wanted to examine it further at the ultrastructural level. To this end we used trans-
mission electron microscopy (TEM) to assess the cellular architecture of the CHT (Fig 6). At
120 hpf, CHT is confined within the space limited dorsally by the caudal artery, ventrally by
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the caudal vein, and laterally by myotomes (Fig 6A). In wt fish the CHT contained a number of
rounded cells supported by deposits of extracellular matrix (ECM) (Fig 6D). In contrast, in
nol9sa1022/sa1022 larvae the CHT area was largely depleted of cells and ECM and instead filled by
electron-loose, possibly necrotic, cell projections full of debris (Fig 6E). As a result, the CHT
area was markedly decreased in nol9sa1022/sa1022 mutants compared to wt siblings (Fig 6B and
6C). Interestingly, we also observed signs of degeneration of endothelial cells in the caudal vein
of nol9sa1022/sa1022 mutants. Endothelial cells seemed “swollen” and contained a high number
of, what appeared to be, lipofuscin granules (Fig 6F and 6G). The accumulation of lipofuscin
granules is often associated with damage to mitochondria, membrane and lysosomes and is
Fig 4. nol9sa1022/sa1022mutants show a decrease in the number of lymphocytes and HSPCs. A) Whole-mount in situ hybridization with lymphocyte-
specific rag1 probe (arrowhead) revealed that nol9sa1022/sa1022 larvae displayed weak to medium rag1 expression at 96 hpf, compared to medium to strong
signal in nol9+/+ or nol9+/sa1022 siblings. Larvae are oriented anterior to the top and ventral up. (B) The number of larvae displaying different degrees of rag1
expression as assessed byWISH. Data are represented as the number of larvae belonging to each phenotypic group. Fisher’s exact test, ** p<0.01. (C)
Whole-mount in situ hybridization against the thymic epitheliummarker foxn1 at 96 hpf revealed a similar level of signal (arrow) in nol9+/+ and nol9sa1022/sa1022
siblings. (D) Whole-mount in situ hybridization using a c-myb riboprobe was used to assess the number of HSCs emerging in the AGM region at 36 hpf
(arrow) and the number of HSPCs in the CHT (arrow) at 72 hpf. Representative pictures of the AGM region (36 hpf) and the CHT (72 hpf) are shown. Mutant
nol9sa1022/sa1022 embryos displayed normal c-myb signal at 36 hpf and decreased c-myb signal at 72 hpf compared to wt siblings. Fisher’s exact test, **,
p<0.01. All embryos are oriented with anterior to the left and dorsal to the top. Numbers represent embryos with the displayed phenotype out of the total
number of embryos examined.
doi:10.1371/journal.pgen.1005677.g004
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implicated in many degenerative diseases [45]. Thus, our TEM analysis further underlines the
complexity of the phenotype observed in nol9sa1022/sa1022 larvae and suggests much broader
changes in the CHT niche, including ECM and endothelial cells.
The pancreatic and hematological defects in nol9sa1022/sa1022 larvae are
mTOR independent
Sufficient protein synthesis is essential for cell growth and proliferation and one of the path-
ways implicated in the regulation of these processes is the Target of Rapamycin (TOR) path-
way. The TOR pathway controls ribosomal protein gene transcription and rRNA synthesis and
processing [46, 47]. To assess whether the defective protein synthesis in nol9sa1022/sa1022 larvae
activates the TOR pathway, we assessed the phosphorylation of the mTOR target 4E-binding
Fig 5. nol9sa1022/sa1022mutants show a decrease in proliferation of c-myb+ cells. (A) Representative maximum projection confocal images showing
HSPCs (GFPdim, arrow) in the CHT of Tg(cd41:EGFP) larvae at 96 hpf. Larvae are oriented with anterior to the left and dorsal to the top. (B) The number of
GFPdim HSPCs observed in the CHT region of nol9sa1022/sa1022mutants (n = 20) and their wt siblings (n = 51) at 96 hpf. Data are represented as the mean +/-
SEM, Student’s t-test, **, p<0.01. (C) Representative confocal images of the CHT of Tg(cmyb:EGFP) embryos subjected to BrdU incorporation assay at 48
hpf. Arrowheads mark double positive BrdU+ c-myb+ cells. Bright field image of a 48 hpf embryo shows the imaged part of the CHT. (D) The total number of
c-myb+ cells observed in the CHT of nol9sa1022/sa1022 embryos (n = 13) and their wt siblings (n = 14) subjected to the BrdU incorporation assay at 48 hpf. Data
are represented as the mean +/- SEM. Student’s t-test. ns—not significant. (E) The percentage of BrdU+ cells within the c-myb+ population in the CHT of
nol9sa1022/sa1022 embryos (n = 13) and their wt siblings (n = 14) subjected to the BrdU incorporation assay at 48 hpf. Data are represented as the mean +/-
SEM, Student’s t-test, *, p<0.05.
doi:10.1371/journal.pgen.1005677.g005
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Fig 6. Ultrastructural studies of caudal hematopoietic tissue (CHT) in nol9sa1022/sa1022 larvae. (A) Schematic representation of a transversal section in
the CHT region of a 120 hpf zebrafish, dorsal up. NT–neural tube, NC–notochord, M—myotome, CA–caudal artery, CHT–caudal hematopoietic tissue, CV–
caudal vein. (B-C) A low-magnification TEM image of the CHT from a nol9+/+ (B, n = 2) and nol9sa1022/sa1022 (C, n = 2) larvae. Dashed line denotes the width of
the CHT. Arrowheads denote mitochondrial profiles visible within myotomes (M). Asterisks denote extracellular matrix (ECM). (D-E) High magnification TEM
image of cells present in the CHT of nol9+/+ (D) and nol9sa1022/sa1022 (E) larvae. (F-G) High magnification TEM image of endothelial cells in the caudal vein of
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protein 1 (p4EBP1) in nol9sa1022/sa1022 and wt larvae. We found no difference in the levels of
phosphorylated p4EBP1 in nol9sa1022/sa1022 larvae compared to nol9+/+ and nol9+/sa1022 siblings
at 120 hpf using Western blot analysis (S12A Fig). In addition, we tested the effect of L-Leucine
on exocrine pancreas and hematopoietic phenotypes in nol9sa1022/sa1022 mutants. L-Leucine
was previously reported to improve the defects resulting from faulty ribosome biogenesis by
activating mRNA translation via the mTOR pathway [17, 48]. In nol9sa1022/sa1022 mutants,
however, the mean volume of the ptf1a-expressing region remained significantly smaller when
compared to nol9+/+ or nol9sa1022/+ larvae regardless of the treatment of embryos with L-Leu-
cine or its inactive enantiomer D-Leucine (S12B and S12C Fig). Similarly, in situ hybridization
against hbae1 revealed that nol9sa1022/sa1022 larvae had significantly lower expression of hbae1
than their nol9+/+ or nol9sa1022/+ siblings at 120 hpf, irrespective of whether they were treated
with L-Leucine, D-Leucine or L-Alanine (S12D Fig). Therefore, we concluded that both the
exocrine pancreas and hematopoietic phenotypes observed in nol9sa1022/sa1022 mutants are
independent of the mTOR pathway. We do not, however, rule out the possibility that defects in
translation of specific mRNAs may occur independently of mTOR and may directly contribute
to the observed phenotype.
The role of tp53 in hematopoiesis and pancreas morphogenesis in
nol9sa1022/sa1022 larvae
Studies have shown that Tp53-dependent mechanisms contribute to the phenotypes resulting
from defective ribosome biogenesis [6–8, 11–13, 15, 16, 49–53]. Publicly available mRNA
expression data generated by the Zebrafish Mutation Project showed that on a whole-organism
level, tp53mRNA is 4.3-fold more abundant in nol9sa1022/sa1022 mutants than in their wt sib-
lings at 120 hpf (adjusted p-value = 6.49 x 10−79) [54]. In order to investigate whether the exo-
crine pancreas phenotype of nol9sa1022/sa1022 larvae is dependent on Tp53 signalling, we
outcrossed the Tg(ins:mCherry)jh2/Tg(ptf1a:EGFP)jh1/nol9+/sa1022 line to the tp53+/zdf1 line [55].
In tp53/zdf1/zdf1 mutant fish, the M214K missense mutation interferes with Tp53 activity by dis-
rupting its DNA-binding domain. We found that at 120 hpf, the mean volume of the ptf1a-
expressing region of nol9sa1022/sa1022/tp53+/+ larvae was not significantly different from that of
nol9sa1022/sa1022/tp53zdf1/zdf1 larvae although both were significantly smaller than the mean vol-
ume of the ptf1a-expressing region of nol9+/+/tp53+/+ and nol9+/+/tp53zdf1/zdf1 larvae (S13A and
S13B Fig). These data suggest that the exocrine pancreas phenotype of nol9sa1022/sa1022 is inde-
pendent of Tp53 signalling.
In order to assess whether the hematopoietic defects observed in nol9sa1022/sa1022 mutants
are Tp53-dependent, we in-crossed nol9+/sa1022/tp53zdf1/+ fish and used their progeny for in
situ hybridization against c-myb and hbae1 at 96 hpf (Fig 7A–7D). Statistical analysis revealed
that in the tp53zdf1/zdf1 background, the level of c-myb signal in nol9sa1022/sa1022 larvae reverted
to wt (nol9+/+;p53+/+) levels (Fig 7A and 7B). In contrast, although nol9sa1022/sa1022/tp53zdf1/zdf1
larvae had a significant increase in the hbae1 in situ signal compared to tp53+/zdf1 and tp53+/+
siblings, the hbae1 signal was still over three-times lower than in wt (nol9+/+/p53+/+) siblings
(Fig 7C and 7D). Therefore, we conclude that in nol9sa1022/sa1022 mutants the defect in the pro-
liferation of HSPCs, but not in the differentiation of definitive erythrocytes, is
Tp53-dependent.
nol9+/+ (F) and nol9sa1022/sa1022 (G) larvae. Arrow denotes vesicles visible in the cytoplasm of the endothelial cell, reminiscent of lipofuscin. E–endothelium.
Scale bars: 2 μm.
doi:10.1371/journal.pgen.1005677.g006
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To further investigate the involvement of Tp53 in the development of defects in different
tissues of nol9sa1022/sa1022 mutants, we assessed the levels of tp53mRNA in nol9sa1022/sa1022
mutants and wt siblings by whole-mount in situ hybridization (Fig 8). At 48 hpf, tp53 was
expressed at high levels in the CHT of nol9sa1022/sa1022 mutants and wt siblings alike (Fig 8A).
Fig 7. The number of HSPCs is rescued in a tp53mutant background. (A) The CHT of 96 hpf larvae from a nol9+/sa1022;tp53+/zdf1 x nol9+/sa1022;tp53+/zdf1
cross stained byWISH against c-myb. Signal extracted from the corresponding WISH photograph is shown. Numbers represent larvae with the displayed
phenotype out of the total number of larvae examined. (B) Quantification of c-myb in situ signal for 96 hpf larvae from a nol9+/sa1022;tp53+/zdf1 x nol9+/sa1022;
tp53+/zdf1 cross, depending on their genotype. Data are represented as the mean number of pixels +/- SEM. nol9+/+;tp53+/+ n = 9; nol9-/-;tp53+/+ n = 11;
nol9-/-;tp53+/zdf1 n = 19; nol9-/-; tp53zdf1/zdf1 n = 10. Two-tailed Student’s t-Test, *, p<0.05; **, p<0.01. (C) Representative pictures of the CHT of 96 hpf
larvae from a nol9+/sa1022;tp53+/zdf1 x nol9+/sa1022;tp53+/zdf1 cross stained byWISH against hbae1. Signal extracted from the corresponding WISH
photograph is shown. (D) Quantification of hbae1WISH signal for larvae from a nol9+/sa1022;tp53+/zdf1 x nol9+/sa1022;tp53+/zdf1 cross, depending on their
genotype. Data are represented as the mean number of pixels +/- SEM. nol9+/+;tp53+/+ n = 16; nol9-/-;tp53+/+ n = 14; nol9-/-;tp53+/- n = 23; nol9-/-;tp53-/-
n = 16. Two-tailed Student’s t-Test, *, p<0.05; **, p<0.01. Within the figure, nol9sa1022 allele has been denoted as nol9- and tp53zdf1 as tp53-.
doi:10.1371/journal.pgen.1005677.g007
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However, at 72 hpf the expression of tp53 remained high in the CHT of nol9sa1022/sa1022
mutants but was down-regulated in wt siblings (Fig 8B). At this stage, tp53 was also signifi-
cantly up-regulated in the liver and intestine of nol9sa1022/sa1022 mutants, but tp53 expression
was not detected in the pancreas of nol9sa1022/sa1022 mutants nor wt siblings (Fig 8C and 8D). In
Fig 8. nol9sa1022/sa1022 embryos display tissue-specific upregulation of tp53. Representative images of
embryos stained by whole-mount in situ hybridization against tp53. (A) At 48 hpf, similar levels of tp53 signal
(arrow) was detected in the CHT of nol9sa1022/sa1022 embryos and their wild-type siblings. (B) At 72 hpf,
nol9sa1022/sa1022mutant embryos were characterized by more tp53 signal in the CHT than their wt siblings.
Mann-Whitney U test, p<0.05. (A-B) All embryos are oriented with anterior to the left and dorsal to the top. (C)
Schematic representation of digestive organs in a wild-type 72 hpf zebrafish larva. I–intestine, L- liver, P-
pancreas. (D) At 72 hpf, nol9sa1022/sa1022mutant embryos display strong tp53 signal in the liver (arrowhead)
and intestine (arrow), compared to weak signal in the intestine of wild-type siblings. (C-D) Dorsal view
anterior up.
doi:10.1371/journal.pgen.1005677.g008
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conclusion, expression of tp53 was detected in the CHT but not in the pancreas prior to the
development of the phenotype in nol9sa1022/sa1022 mutants, i.e. 48 hpf for the CHT and 72 hpf
for the pancreas.
Discussion
In this study, we have characterized the phenotype of the loss-of-function nol9sa1022/sa1022 zeb-
rafish mutant. We have shown that in zebrafish, similar to human, Nol9 is involved in 28S
rRNA processing. In addition, nol9sa1022/sa1022 larvae had impaired development of the intes-
tine, liver, pancreas and definitive erythrocytes and lymphocytes, thus recapitulating several
common features of ribosomopathies in human.
Although ribosomopathies have a wide spectrum of clinical manifestations, many are char-
acterized by hypoproliferative phenotypes. Zebrafish harboring a loss-of-function nol9sa1022
mutation displayed an early hypoproliferative defect restricted to progenitor cells of the diges-
tive and hematopoietic systems. Both ptf1a-positive progenitor cells of the exocrine pancreas
and cmyb-positive HSPCs had significantly lower rates of proliferation in nol9sa1022/sa1022 larvae
compared to their wt siblings. This tissue specific phenotype can be partially explained by the
distinct expression pattern of nol9. Indeed, we observed that nol9 was most highly expressed in
branchial arches, liver, pancreas, as well as caudal hematopoietic tissue at 120 hpf. Alterna-
tively, Nol9 may have tissue-specific interacting partners and extra-ribosomal functions in the
digestive organs and in HSPCs [56, 57]. Furthermore, it has been proposed that the spectrum
of translated mRNAs might change with the overall reduction of fully functional cytoplasmic
ribosomes or specific ribosomal biogenesis proteins, suggesting that ribosome composition
may vary between distinct cell types [56–58]. Another explanation for the tissue specific effect
of nol9 depletion stems from the high proliferative rate of the affected tissues. The reason for
this is twofold. Firstly, it is reasonable to speculate, that highly proliferative cell populations,
such as pancreatic cells and HSPCs, deplete maternally-derived Nol9 protein earlier than other
cell populations [58]. And secondly, defects in ribosomal biogenesis affect primarily highly
proliferative cells due to their high demand for ribosome production. This is particularly ger-
mane to HSCs which are shown to be very sensitive to changes in the level of protein synthesis
[59].
Impaired development of the pancreas, liver and intestine has been a recurrent pathological
feature in many zebrafish models of ribosomopathies, including nil per os (npo) [60], digestive
expansion factor (def) [8], titania (tti) [61] and nucleolar protein with MIF4G domain 1 (nom1)
[62]. In contrast, the hematopoietic defects have been studied to a lesser extent; the reported
phenotypes are usually limited to primitive erythropoiesis or specification of HSCs as in rpl11,
rps19, rps7, rps29 and nop10mutants [16, 18, 53, 63, 64]. In our nol9sa1022/sa1022 model, primi-
tive erythropoiesis, as well as specification of HSCs, was normal. However, the nol9sa1022/sa1022
larvae had decreased numbers of definitive erythroid and lymphoid cells, whereas the number
of thrombocytes remained within the normal range at 96 hpf. Thus, to the best of our knowl-
edge, the nol9sa1022/sa1022 mutant is the only zebrafish model of ribosomopathy in which the
later stages of definitive hematopoiesis have been described. Although blood defects were ini-
tially restricted to specific lineages, the whole hematopoietic tissue appeared degenerated at
120 hpf. The CHT of the nol9sa1022/sa1022 larvae was largely depleted of cells and ECM and filled
with a number of cell projections that were reminiscent of cells undergoing necrosis. Interest-
ingly, we also detected signs of pathological processes in endothelial cells of the caudal vein.
The endothelial cells appeared swollen and filled with lipofuscin granules, featuring structural
changes not previously reported in other zebrafish models of ribosomopathy. Therefore, the
Role of Nol9 in Haematopoiesis and Pancreas Morphogenesis in Zebrafish
PLOS Genetics | DOI:10.1371/journal.pgen.1005677 December 1, 2015 15 / 28
phenotype of the nol9sa1022/sa1022 mutants should be viewed as a progressive degenerative pro-
cess, which culminates with the death of larvae by 10 dpf.
It is hypothesized that impaired ribosomal biogenesis promotes excess free ribosomal pro-
teins in the nucleus, resulting in nucleolar stress. In response to this stress, free ribosomal pro-
teins (including RPL5, RPL11, RPL23, RPS7 and RPL26) bind and inactivate MDM2, which
results in Tp53 stabilization and Tp53-dependent cell cycle arrest [65–71]. However, Tp53-in-
dependent processes involving cell cycle arrest and apoptosis due to ribosome biogenesis
defects have been also described [72–75]. As in nom1, tti, pes, rpl3, rpl23a and rpl6mutants, the
defect in pancreatic development in nol9sa1022/sa1022 mutants was Tp53-independent [61, 62,
76, 77]. In rpl11mutants, defects in specification of HSCs as well as primitive erythropoiesis
were Tp53-dependent [16]. Similarly, mice with heterozygous mutations in ribosomal genes
Rps20 and Rps19 had a tp53-mediated decrease in the number of erythrocytes [78]. Interest-
ingly, in our nol9sa1022/sa1022/tp53zdf1/zdf1 double mutant model, the number of HSPCs in the
CHT was restored to wt levels, whereas the number of definitive erythrocytes was only partially
rescued. This suggests that in nol9sa1022/sa1022 mutants there are two independent hematopoi-
etic defects—one affecting HSPC proliferation and the other affecting definitive erythrocyte
differentiation. Interestingly, we observed high expression of tp53 in the CHT of wt and
nol9sa1022/sa1022 embryos at 48 hpf, which suggests that Tp53 may play a developmental role in
HSPCs before 72 hpf, which could account for the different responses of HSPCs, definitive
erythrocytes and exocrine pancreas to the loss of tp53 in nol9sa1022/sa1022 mutants.
It has been speculated that disruption in translational machinery in erythroid precursors
leads to anemia in many ribosomopathies [3]. For example, altered translation of the key ery-
throid transcription factor GATA-1 has also been reported in DBA [79]. The late stage ery-
throid cells exhibit rapid cell division and extensive translational demand for globin synthesis.
Therefore, anemia may be attributed to the hypersensitivity of these cells to the reduced level of
mRNA translation. Treatment of embryos with amino acid L-Leucine, a potent activator of the
mTOR pathway and mRNA translation, has been shown to alleviate anemia in rps14 and rps19
morpholino knock-down zebrafish embryos [17, 80]. In nol9sa1022/sa1022 mutants, L-Leucine
treatment did not rescue the erythroid or pancreatic phenotype suggesting that these are inde-
pendent of mTOR.
The phenotypic features of the nol9sa1022/sa1022 mutants are highly reminiscent of the tissue
specific clinical features of Shwachman-Diamond syndrome (SDS) that is associated with defi-
ciency of the SBDS (Shwachman-Bodian-Diamond Syndrome) protein [24]. SBDS plays a role
in the same process as NOL9, although at a later stage: it is required for late cytoplasmic matu-
ration of 60S ribosomal subunits and translational activation of ribosomes [25–27]. In zebra-
fish, sbds and nol9 are both highly expressed in the pancreas at 120 hpf [77, 81]. In addition,
MO knock-down of sbds leads to a Tp53-independent defect in the development of the exo-
crine, but not endocrine pancreas [77], in line with the phenotype observed in nol9sa1022/sa1022
mutants. The involvement of SBDS and NOL9 in 60S ribosomal subunit biogenesis, coupled
with the remarkable similarity of the phenotypes resulting from depletion of both genes in zeb-
rafish (some of which mimic clinical manifestations of SDS) strongly supports the view that
nol9sa1022/sa1022 mutant zebrafish are a highly relevant, valuable ribosomopathy model system.
Our study describes the zebrafish nol9sa1022/sa1022 mutant, a novel vertebrate model of ribo-
somopathy, which recapitulates key human disease characteristics. Further characterisation of
the nol9sa1022/sa1022 mutant will foster insights into the molecular pathology of ribosomopathies
and provide fundamental new insights into how ribosome dysfunction leads to tissue-specific
pathologies. Ultimately, the use of good genetically tractable models, such as the zebrafish
nol9sa1022/sa1022 mutant, will have significant impact not only on our understanding of the
Role of Nol9 in Haematopoiesis and Pancreas Morphogenesis in Zebrafish
PLOS Genetics | DOI:10.1371/journal.pgen.1005677 December 1, 2015 16 / 28




The maintenance, embryo collection and staging of the wild type (Tubingen Long Fin) and
transgenic and mutant zebrafish lines (Tg(cd41:EGFP), Tg(c-myb:EGFP), Tg(ptf1a:EGFP), Tg
(ins:mCherry), tp53zdf1, nol9sa1022) were performed in accordance with EU regulations on labo-
ratory animals, as previously described [82, 83]. Melanization of embryos was prevented by
incubating embryos with 0.002% phenylthiourea (PTU, Sigma Aldrich) from 24 hpf.
Genotyping
DNA isolation and genotyping using allele-specific probes were performed as previously
described [84].
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed with gene-specific probes against c-myb,
rag1, hbae1, prox1, fabp2, foxn1 and tp53 as previously described [85]. Primers used for
probe synthesis against nol9 were: 5’-GACAATGAAAGTACACAAGGTTC-3’ (forward) and
5’-TAATACGACTCACTATAGGGTAACACTGCACGGTTCTTGG-3’ (reverse). The ribop-
robe was synthesized by in vitro transcription using T7 polymerase, with the PCR product
used as the template.
Quantification of prox1WISH signal was performed by measuring the area of stained tissue
in ImageJ.
Quantification of hbae1 and c-mybWISH signal in the CHT region was performed in an
objective manner by counting the number of pixels with color within a prescribed distance
from a given color in each TIFF image. The particular values used were (100,100,120) color in
the RGB space with tolerance of 16% of maximum possible intensity for hbae1 and 10% for
c-myb. Calculations were carried out by ImageMagick raster image processing software suite
controlled by a Bash script that automated processing and collecting of data. Images were
cropped prior to the procedure in order to include the whole CHT region and to prevent acci-
dental misclassification of pixels without signal. Masks consisting of classified pixels were visu-
ally inspected for accuracy.
In order to quantify the level of tp53WISH signal in the CHT at 72 hpf, two observers inde-
pendently classified the larvae into four groups according to the strength of the signal in a
blinded manner. The difference between the signal in nol9sa1022/sa1022 larvae and wt siblings,
assessed with Mann-Whitney U test, was significant (p<0.05) in each case.
Whole-mount immunohistochemistry
Whole-mount immunohistochemistry was performed as described before [86], with incuba-
tion in 0.1% collagenase (Sigma) in PBS-Tween for 30 min for the digestion step. For immuno-
histochemistry against glucagon and somatostatin, larvae were deyolked before incubation in
blocking buffer. Primary antibodies used were anti-cytokeratin (Santa Cruz Biotechnology,
1:50), anti-glucagon (Sigma, 1:1,000), anti-somatostatin (Dako, 1:200) and anti-carboxypepti-
dase-a (Sigma, 1:100). The larvae were mounted with Vectashield Mounting Media (Vector
Laboratories).
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Microscopy
Images of live larvae, as well as larvae treated with WISH and histochemical stains, were taken
using either a Leica DFC 450 CCD camera attached to a Leica LM80 or MZ16 FA dissecting
microscope and Leica Application Suite software (Leica Microsystems, Germany), or an Axio-
Cam ICc1 camera attached to a Leica AxioZoom.V16 microscope with ZEN software (Carl
Zeiss, Germany).
Confocal images were captured using a Leica TCS SP5 confocal microscope with Leica LAS
AF software (Leica Microsystems), using a 20x or 40x lens. The volume of the ptf1a-positive
exocrine pancreas in Tg(ptf1a:EGFP) larvae was measured from a z-stack of confocal pictures,
using ImageJ 1.48v programme, with a 10 μm slice interval using the Measure Stacks plugin in
the ImageJ64 software (National Institutes of Health (NIH), http://imagej.nih.gov/ij/).
5-bromo-2'-deoxyuridine (BrdU) incorporation assay
Embryos at either 48- or 72 hpf were incubated in 10mM BrdU (Sigma Aldrich) for 20 min on
ice, washed in egg water and incubated at 28°C for 3 h (48 hpf) or 5h (72 hpf). The embryos
were then used for immunohistochemistry with anti-GFP primary antibody (Invitrogen,
1:200) and anti-rabbit secondary antibody conjugated to Alexa Fluor 488 (Invitrogen, 1:200),
followed by fixation with 4% paraformaldehyde at room temperature for 15 min. The embryos
were then cut and their heads were used for genotyping. Embryos of the same genotype were
pooled together and subjected to washes with water followed by treatment with 2N HCl for 1h
at room temperature. The embryos were then washed consecutively with PBS-Tween and 1M
Tris-HCl pH 9.5 and subjected to immunohistochemistry against BrdU with rat anti-BrdU
antibody (Abcam, 1:200) and anti-rat antibody conjugated to Cy3 (Millipore, 1:400). Fluores-
cence was visualized using confocal microscopy.
TUNEL assay
For assessment of apoptosis in the pancreas, the TUNEL assay was performed on 96 hpf larvae
using In situ Cell Death Detection Kit, TMR Red (Roche). Fixed larvae were digested in 0.1%
collagenase (Sigma) before staining. The larvae were counterstained with DAPI and imaged
using confocal microscopy.
For assessment of apoptosis in the CHT of 96 hpf larvae, In situ Cell Death Detection Kit,
AP (Roche) was used. After incubation with TUNEL reaction mixture, larvae were heated to
80°C for 10 min. After blocking in a solution of 5% heat inactivated Fetal Bovine Serum in
PBS-Tween, the larvae were incubated overnight with anti-fluorescein Fab fragments conju-
gated to alkaline phosphatase (Roche, 1:2,000) and stained with NBT/BCIP solution (Roche),
according to the manufacturer’s protocol.
Flow cytometry
The progeny from a Tg(c-myb:EGFP/nol9+/sa1022 x nol9+/sa1022 cross at 96 hpf was screened for
the presence of EGFP and subjected to immunohistochemical staining with anti-GFP primary
antibody (Invitrogen, 1:200) and anti-rabbit secondary antibody conjugated with Alexa Fluor
488 (Invitrogen, 1:200). Afterwards, each larva was dissected: the CHT was stored and the rest
of the body was used for genotyping for the nol9sa1022 allele. CHTs from 8 larvae of the same
genotype were pooled, incubated for 30 min with 10 mMDTT (Life Technologies) in
Danieau’s solution, followed by incubation with 50 μg/ml liberase (Roche) in PBS for 3 h at
37°C. Single-cell suspension was prepared by passing the solution through a 40 μmmesh cell
strainer (Becton Dickinson). Flow cytometry was performed on a BD LSR-Fortessa analyzer
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(Becton Dickinson). Non-transgenic siblings subjected to immunohistochemical staining were
used as a negative control.
Western blot analysis
Western blotting was performed using the NuPAGE SDS-PAGE gel system (Novex), according
to the manufacturer’s protocol. The following antibodies were used at the dilutions indicated:
anti-phospho-4EBP1 (Cell Signalling, 1:200) and anti-β-actin (Sigma Aldrich, 1:1,000). Sec-
ondary antibodies conjugated with horseradish peroxidase (HRP) were used at 1:50,000 dilu-
tion. The signal was developed with a SuperSignal West Femto Substrate kit (Thermo
Scienctific) and visualized using an ImageQuant LAS 4000 instrument (GE Healthcare Life
Sciences).
Transmission electron microscopy (TEM)
For TEM, 120 hpf larvae from a cross of Tg(ptf1a:EGFP);nol9+/sa1022 fish were genotyped and
fixed in 2% glutaraldehyde and 2% formaldehyde in 0.05 M cacodylate buffer at pH 7.4 for 6
hours at 4°C. They were then processed for infiltration with Quetol epoxy resin as described
previously [87]. Images were taken on an FEI Tecnai G2 operated at 120Kv using an AMT
XR60B digital camera running Deben software. Transverse sections through the caudal
hematopoietic tissue (CHT), as well as longitudinal sections through the pancreas were
obtained.
Histochemical stains
Alcian blue staining was performed on 120 hpf larvae as described previously [88].
o-Dianisidine staining for globin was performed as previously described [89]. The o-Diani-
sidine signal was quantified using an analogous method to the one used for the quantification
of c-myb and hbae1WISH signal.
Sudan Black B staining for visualization of neutrophil granules was performed as previously
described [90].
Chemical treatment
N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t- butyl ester (DAPT, StressMarq)
was used to inhibit Notch signaling. Larvae were incubated in 100 μMDAPT in egg water con-
taining PTU from 72 hpf until 120 hpf.
For studies involving the mTor pathway, embryos from a cross of nol9+/sa1022 fish were
incubated in 100 mM solution of L-Leucine, D-Leucine or L-Alanine (Sigma) in egg water with
addition of PTU from 24 hpf until 120 hpf.
Northern blot
Total RNA from phenotypic and non-phenotypic larvae at 120 hpf was isolated using phenol:
chloroform extraction. 2 μg of total RNA per lane was subjected to electrophoresis on a 0.8%
agarose gel (with the addition of 7% formaldehyde) in 1xMOPS/1% formaldehyde buffer. RNA
was then blotted to a Hybond-Nylon membrane (Amersham) and subsequently visualized
using methylene blue staining. The detection of rRNA precursors was performed using the
High Prime DNA Labeling and Detection Starter Kit II (Roche) kit, according to manufactur-
er’s protocol. The DNA probes targeted 5’ETS, ITS1, and ITS2 rRNA [61]. The signal was
detected using an X-ray film (Kodak).
Role of Nol9 in Haematopoiesis and Pancreas Morphogenesis in Zebrafish
PLOS Genetics | DOI:10.1371/journal.pgen.1005677 December 1, 2015 19 / 28
Analysis of 28S and 18S rRNA levels
Total RNA extracted from 120 hpf nol9sa1022/sa1022 larvae and their wt siblings was analyzed on
an Agilent Bioanalyser 2100 according to the manufacturer’s instructions.
Analysis of protein synthesis
Global protein synthesis was assessed using puromycin incorporation [91]. An equal number
of nol9sa1022/sa1022 and wt 120 hpf larvae were suspended in blocking solution (5% FBS / PBS),
with the addition of 20 μg/ml puromycin (Sigma) and 100 μg/ml cycloheximide (Santa Cruz
Biotechnology), where applicable. Larvae were dissociated by passing through 100 μmmesh
and the cell suspension was incubated at room temperature for 10 min, followed by centrifuga-
tion at 2,000 rpm for 3 min. The pellets were re-suspended in blocking solution (with the addi-
tion of 100 μg/ml cycloheximide, where applicable) and incubated at 28°C for 40 min. After
centrifugation, cell pellets were used for Western blot analysis using anti-puromycin antibody
(1:150, kind gift from Yusuke Sekine) and anti-β-actin antibody (Sigma Aldrich, 1:1,000) for
loading control. Signal strength was quantified by densitometry measurements using ImageJ.
For β-actin, the single band was quantified. For puromycin, an area of gel with the weakest
background (the signal in the no puromycin control) was chosen. For each lane, the full signal
within the chosen area was measured and the value for the background was subtracted. The
puromycin signal value was then divided by the β-actin value for the same sample.
Gene knock-down with morpholinos (MOs)
Morpholinos (Gene-Tools) were diluted in distilled water with 0.25% phenol red (Sigma)
and injected into 1- to 2-cell stage embryos at 4 ng. The MO sequences were: nol9 ATGMO:
5’- ACCTTGTGTACTTTCATTGTCATCC-3’, Std Ctrl MO 5’-CCTCTTACCTCAGTTAC
AATTTATA-3’.
Statistical methods
Statistical analyses were performed in Microsoft Excel and Statplus (AnalystSoft).
Supporting Information
S1 Fig. nol9mutation affects the development of liver and intestine but not of jaw cartilage.
(A) Representative pictures of 96 hpf larvae stained by WISH against the liver marker prox1
(black arrow). Magnified images of the liver are shown. (B) Quantification of the prox1 in situ
hybridization data. The average prox1-positive area is decreased in nol9sa1022/sa1022 mutants
(n = 13) compared to wild-type siblings (n = 25). Data are represented as the average +/- SEM.
Two-tailed Student’s t test, , p<0.001. (C) Representative images of 96 hpf larvae stained by
WISH against the intestinal marker fabp2a. The expression of fabp2a (blue arrow) is decreased
in nol9sa1022/sa1022 (n = 11) compared to wild-type siblings (n = 32). (D) Alcian blue staining,
showing normal formation of the jaw cartilage elements Meckel’s (m), palatoquadrate (pq),
ceratohyal (ch) and ceratobranchial (cb) in both nol9sa1022/sa1022 mutants (n = 23) and wt sib-
lings (n = 54) at 120 hpf. Ventral view with anterior to the left.
(TIFF)
S2 Fig. Definitive, but not primitive erythropoiesis is affected in nol9sa1022/sa1022 mutants.
(A-D) o-Dianisidine staining of circulating erythrocytes at 48 hpf, 96 hpf and 120 hpf. (A) Repre-
sentative images of o-Dianisidine-stained embryos at 48 hpf. The level of staining was similar
between nol9+/+ (n = 13), nol9+/sa1022 (n = 35) and nol9sa1022/sa1022 (n = 8) embryos. Ventral view
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with anterior up. (B) Representative images of o-Dianisidine-stained larvae at 96 hpf. The num-
ber of stained circulating primitive erythrocytes was comparable between nol9sa1022/sa1022
(n = 10), nol9+/+ (n = 15) and nol9+/sa1022 (n = 15) siblings. Ventral view with anterior up. (C)
Quantification of the area stained in o-Dianisidine-stained larvae area at 96 hpf. Data are repre-
sented as average +/- SEM. Two-tailed Student’s t test, p>0.05. ns–not significant. (D) Represen-
tative images of o-Dianisidine-stained larvae at 120 hpf. All nol9sa1022/sa1022 (n = 20), nol9+/+
(n = 2) and nol9+/sa1022 (n = 8) larvae displayed a similar level of staining. Larvae oriented with
anterior to the left and dorsal to the top. (E) Whole-mount in situ hybridization using hbae1
riboprobe at 96 hpf. Arrows indicate hbae1-positive definitive erythrocytes present in the CHT of
nol9+/sa1022 and nol9+/+ but not in nol9sa1022/sa1022 larvae. (F) Quantification of hbae1 in situ
hybridization data. Data are represented as the number of larvae belonging to each phenotypic
group. Fisher’s exact test, , p<0.01.
(TIFF)
S3 Fig. nol9mutation affects the 28S/18S rRNA ratio. (A) Representative E-Bioanalyser anal-
ysis of total RNA isolated from nol9sa1022/sa1022 mutants and their wt siblings at 120 hpf. Peaks
corresponding to 18S (arrowhead) and 28S (arrow) are indicated. (B) 28S/18S ratio in
nol9sa1022/sa1022 larvae and wt siblings, based on the E-Bioanalyser analysis of total RNA. Data
are represented as average +/- SD, nreplicates = 4, paired Student’s t-test, , p<0.05.
(TIFF)
S4 Fig. nol9sa1022/sa1022 mutants have a defect in development of the exocrine but not the
endocrine pancreas. (A) Representative confocal images of the pancreas of Tg(ptf1a:EGFP;ins:
mCherry) fish at 48-, 72- and 120 hpf. No difference was observed between nol9sa1022/sa1022 and
wt siblings at 48- and 72 hpf. At 120 hpf the area of the ptf1a+ exocrine pancreas (green) was
decreased in nol9sa1022/sa1022 larvae, while the area of ins+ endocrine pancreas (red) was compa-
rable in nol9sa1022/sa1022 mutants and wt siblings. (B) Confocal images of the endocrine pan-
creas of larvae subjected to immunohistochemistry against Somatostatin and Glucagon at 96
hpf. The intensity and area covered by the signal was comparable in nol9sa1022/sa1022 larvae and
wt siblings for both antibodies. (C) Average volume of the ptf1a-positive exocrine pancreas in
nol9sa1022/sa1022 (n = 8) and wt (n = 15) larvae at 120 hpf. Data are represented as the mean +/-
SEM, Student’s t-test, , p<0.01. All images are oriented with anterior to the right and dorsal
to the top.
(TIFF)
S5 Fig. Gene knockdown studies using nol9morpholino confirm the pancreas phenotype
observed in nol9sa1022/sa1022 mutants. (A) General morphology of 96 hpf larvae injected with
either standard control morpholino (std MO) or a morpholino targeting the translational start
site of the nol9 transcript (nol9 ATGMO). Numbers represent larvae with the displayed phe-
notype out of the total number of larvae examined. (B) Representative confocal images of the
pancreas of 96 hpf Tg(ptf1a:EGFP;ins:mCherry) larvae injected with std MO or nol9 ATGMO.
While the ptf1a+ exocrine pancreas appeared smaller in larvae injected with nol9 ATGMO
compared to std MO, the ins+ endocrine pancreas was comparable between the groups. (C)
The average volume of the ptf1a+ exocrine pancreas in 96 hpf larvae injected with std MO
(n = 19) or nol9 ATGMO (n = 25). Data are represented as the mean +/- SEM, Student’s t-test,
, p<0.01.
(TIFF)
S6 Fig. Global protein synthesis in zebrafish larvae assessed by western blotting for puro-
mycin incorporation. (A) Western blot analysis of puromycin following its incorporation into
newly synthesized proteins in nol9sa1022/sa1022 mutants and wt siblings at 120 hpf. β-actin was
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detected as a loading control. P–puromycin, CHX–cycloheximide. (B) The average intensity of
puromycin signal, standardized by β-actin signal. Data are represented as the mean +/- SEM.
Student’s t-test, , p<0.01, ns–not significant, CHX—cycloheximide.
(TIFF)
S7 Fig. Formation of secondary islets and apoptosis levels in pancreas are unaffected in
nol9sa1022/sa1022 mutants. (A) Representative confocal images of the pancreas of 120 hpf Tg
(ptf1a:EGFP;ins:mCherry) larvae showing the presence of ins-expressing secondary islets (arrow)
in nol9sa1022/sa1022mutants and wt siblings. (B) The percentage of Tg(ptf1a:EGFP;ins:mCherry)
larvae whose pancreas contained secondary islets, depending on their genotype and previous
treatment with either DAPT inhibitor or DMSO (vehicle control) at 120 hpf. The total number
of larvae in each group is indicated. (C) Representative confocal images of Tg(ptf1a:EGFP) larvae
subjected to TUNEL assay at 96 hpf and co-stained with DAPI. No TMR-labelled apoptotic cells
were observed in the ptf1a-expressing exocrine pancreas of nol9sa1022/sa1022mutants (n = 8) or
their wt siblings (n = 9). However, the tails of nol9sa1022/sa1022mutants and wt siblings contained
similar numbers of apoptotic cells (arrow). (D) The mean number of apoptotic cells in the tails of
nol9sa1022/sa1022mutants (n = 8) and wt siblings (n = 9). Data are represented as the mean +/-
SEM; Student’s t-test, ns–not significant.
(TIFF)
S8 Fig. Proliferation of exocrine pancreas cells in nol9sa1022/sa1022 mutants. (A) Representa-
tive confocal images of Tg(ptf1a:EGFP) larvae subjected to BrdU incorporation assay at 96 hpf.
Double positive ptf1a+ BrdU+ cells are indicated with arrows. Images are oriented with anterior
to the right and dorsal to the top. (B) Average number of ptf1a+ cells which incorporated
BrdU, normalized to the volume of ptf1a+ exocrine pancreas, in nol9sa1022/sa1022 (n = 9) and wt
(n = 7) larvae at 96 hpf. Data are represented as the mean +/- SEM. Student’s t-test, p = 0.051.
(TIFF)
S9 Fig. The number of thrombocytes and neutrophils is unaffected in nol9sa1022/sa1022
mutants. (A) Representative maximum projection confocal images showing thrombocytes
(GFPbright, arrow) and HSPCs (GFPdim, arrowhead) in the CHT of Tg(cd41:EGFP) larvae at 96
hpf. Larvae are oriented with anterior to the left and dorsal to the top. (B) The number of
GFPbright thrombocytes observed in the CHT region of nol9sa1022/sa1022 mutants (n = 20) and
their wt siblings (n = 51) at 96 hpf. Data are represented as the mean +/- SEM; Student’s t-test,
p>0.05. (C) Images of the CHT region of 72 hpf larvae stained with Sudan Black B. Stained
neutrophils are marked by an arrow. (D) The average number of Sudan Black B-stained neu-
trophils in the CHT region of 72 hpf larvae, depending on their genotype (nol9+/+ n = 32,
nol9+/sa1022 n = 32 and nol9sa1022/sa1022 n = 28). Data are represented as the mean +/- SEM;
One-way ANOVA, ns–not significant.
(TIFF)
S10 Fig. Analysis of the number of c-myb+ cells in the CHT of nol9sa1022/sa1022 mutants. (A)
Representative results of flow cytometric analysis of the number of c-myb+ cells in the CHT of
nol9sa1022/sa1022 and nol9+/+ larvae, using the progeny of a nol9+/sa1022 Tg(c-myb:EGFP) x nol9+/sa1022
cross at 96 hpf. Non-transgenic siblings were included as a negative control. Gating of the GFP+
population is shown. (B) The number of c-myb+ cells in the CHT of 96 hpf Tg(c-myb:EGFP)
nol9sa1022/sa1022 and nol9+/+ larvae analysed by flow cytometry. Data are represented as the percent-
age of GFP+ cells within the single cell population. Student’s t-Test, n = 2, , p<0.05. (C) Average
intensity of the GFP signal for c-myb+ cells in the CHT of 96 hpf Tg(c-myb:EGFP) nol9sa1022/sa1022
and nol9+/+. Only the cells gated as shown in (A) were included. Data represented as average +/-
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SEM. Student’s t-Test, n = 2, p>0.05, ns–not significant.
(TIFF)
S11 Fig. Apoptosis in the CHT assessed by TUNEL assay. (A) The CHT region of 72 hpf lar-
vae stained with TUNEL assay. nol9sa1022/sa1022 mutants do not exhibit an increase in the num-
ber of TUNEL-positive apoptotic cells (arrow) compared to wt siblings in the CHT region (as
outlined). All larvae are oriented with anterior to the left and dorsal to the top. (B) The average
number of TUNEL-positive apoptotic cells in the CHT region in nol9+/+ (n = 16), nol9+/sa1022
(n = 34) and nol9sa1022/sa1022 (n = 15) larvae at 72 hpf. Data are represented as the mean +/-
SEM; One way ANOVA, ns–not significant.
(TIFF)
S12 Fig. The pancreatic and hematological defects in nol9sa1022/sa1022 larvae are indepen-
dent of the mTOR pathway. (A) Western blot analysis of p4EBP1 and β-actin (loading con-
trol) in whole cell lysates of nol9sa1022/sa1022 and wt siblings at 120 hpf. (B) Representative
confocal images of the pancreas of Tg(ptf1a:EGFP) nol9sa1022/sa1022 and nol9+/+ larvae at 120
hpf after treatment with L-Leucine or D-Leucine from 24 hpf. (C) The average volume of the
ptf1a-positive exocrine pancreas in 120 hpf Tg(ptf1a:EGFP) larvae, depending on their geno-
type and treatment with either D-Leucine or L-Leucine from 24 hpf. The data are represented
as the mean +/- SEM. Student’s t-test, , p<0.01. (D) Quantification of hbae1WISH per-
formed on 120 hpf larvae treated with D-Leucine, L-Leucine or L-Alanine from 24 hpf. Data
are represented as the number of wt (nol9+/+/nol9+/sa1022) or mutant (nol9sa1022/sa1022) larvae
belonging to either phenotypic group. Fisher’s exact test, , p<0.01.
(TIFF)
S13 Fig. The exocrine pancreas phenotype of nol9sa1022/sa1022 mutants is independent of
Tp53 signalling. (A) Confocal images of the pancreas of 120 hpf larvae from a Tg(ptf1a:
EGFP);nol9+/sa1022;tp53+/zdf1 x nol9+/sa1022;tp53+/zdf1 cross. (B) The average volume of the
ptf1a+ exocrine pancreas of 120 hpf larvae from a Tg(ptf1a:EGFP);nol9+/sa1022;tp53+/zdf1 x
nol9+/sa1022;tp53+/zdf1 cross, depending on their genotype. Data are represented as the mean +/-
SEM. Student’s t-test, , p<0.01, ns–not significant. Within this figure, nol9sa1022 allele has
been denoted as nol9- and tp53zdf1 as tp53-.
(TIFF)
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